COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2016

Jun 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2016-06-09

Reporting Person: Nadav Eran (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-09	Stock Option (Right to Purchase)	$16.49	A	8700	Acquired	2026-06-09	Common Stock (8700)	Direct

Footnotes

F1: The option vests and becomes exercisable on June 9, 2017, subject to the director's continued service with the issuer.